Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer [Phase 2]
Phase 2 trial update for anlotinib and AK105 injection in advanced head, neck, and chest cancer.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 1]
Phase 1 dose-finding trial evaluating metformin in combination with chemoradiation for locally advanced head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer [Phase 2]
Phase 2 trial evaluating induction chemotherapy with carboplatin/paclitaxel followed by concurrent chemoradiation including ZD1839 (Iressa),…
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 clinical trial investigating concomitant camrelizumab with chemoradiation for locally advanced head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck [Phase 4]
A Phase 4 clinical trial comparing cetuximab with mitomycin-C and 5-fluorouracil for locally advanced head and neck squamous cell carcinomas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]
Phase 2 trial in locally advanced squamous cell carcinoma of the head and neck was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Everolimus Versus Placebo in Head and Neck Cancer [Phase 2]
A Phase 2 trial comparing everolimus to placebo in head and neck cancer has terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx [Phase 3]
A Phase 3 clinical trial evaluating interventions for oral mucositis in patients receiving radiation therapy for head and neck cancers has c…
-
CLINICAL_TRIALS trial_result · 2020-03-23Clinical Trial Update: Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of SCT200 in head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 clinical trial evaluating capecitabine and lapatinib ditosylate in various forms of head and neck squamous cell carcinoma has comple…
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract [Phase 2]
Phase 2 trial investigating cetuximab for precancerous lesions of the upper aerodigestive tract; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Targeting the Tumor Microenvironment in R/M SCCHN [Phase 1, Phase 2]
Phase 1/2 trial update focusing on tumor microenvironment in recurrent/metastatic squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Study of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Clinical trial update for RM-1929 photoimmunotherapy in recurrent head and neck cancer has completed Phase 1 and Phase 2 studies.
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Positron Emission Tomography/Magnetic Resonance Imaging in Patients [NA]
Clinical trial focusing on PET/MRI imaging in cancer patients has been terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer [Phase 4]
A Phase 4 clinical trial comparing Lymphoseek to Albumin Nanocolloid in head and neck cancers, melanoma, and breast cancer is ongoing with u…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy [NA]
Completed clinical trial evaluating DMH-based plan evaluation and inverse optimization in radiotherapy for head and neck and lung cancers, w…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy [Phase 2]
Phase 2 trial evaluating epacadostat with pembrolizumab in head and neck cancer that progressed after prior immunotherapy; study terminated …
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer [Phase 3]
A Phase 3 trial comparing radiation therapy with cisplatin versus cetuximab in patients with oropharyngeal cancer has completed enrollment a…
-
CLINICAL_TRIALS withdrawal · 2019-12-20Clinical Trial Update: Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) [Phase 3]
Phase 3 trial CheckMate 9NA/ECHO-310 evaluating nivolumab plus epacadostat with chemotherapy versus EXTREME in squamous cell carcinoma of th…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 2]
Phase 2 trial of docetaxel, cisplatin, and cetuximab (TPC) in palliative treatment for head and neck squamous cell carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients [Phase 2]
Phase 2 trial update evaluating pentoxifylline and vitamin E for radiotherapy-induced toxicity in head and neck cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS) [Phase 2]
Phase 2 clinical trial update for high-risk recurrent or second primary head and neck cancer using a PD-1 antibody as adjuvant after salvage…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial update evaluating cetuximab added to concurrent chemoradiotherapy platforms for locally advanced head and neck cancer; results…